X4 Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 16.92 M | $11.32 M | 0.00% | 8.42% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 14.99 M | $10.04 M | 0.00% | 7.46% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 11.21 M | $7.50 M | 100.00% | 5.58% |
| VANGUARD GROUP INC | 11/13/2024 | 8.44 M | $5.65 M | 1.82% | 4.20% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 7.13 M | $4.77 M | 0.00% | 3.55% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2024 | 4.64 M | $3.10 M | 0.32% | 2.31% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 4.28 M | $2.86 M | 0.00% | 2.13% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 3.55 M | $2.37 M | 0.00% | 1.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.45 M | $2.31 M | -1.94% | 1.72% |
| AXA S.A. | 11/14/2024 | 3.08 M | $2.06 M | 0.03% | 1.53% |
| STATE STREET CORP | 11/14/2024 | 2.95 M | $1.98 M | 6.84% | 1.47% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 2.55 M | $1.70 M | 0.00% | 1.27% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 1.92 M | $1.29 M | 51.28% | 0.96% |
| PALE FIRE CAPITAL SE | 11/12/2024 | 1.60 M | $1.07 M | 805.37% | 0.80% |
| UBS OCONNOR LLC | 11/14/2024 | 1.55 M | $1.04 M | 33.51% | 0.77% |
| NORTHERN TRUST CORP | 11/13/2024 | 1.32 M | $883,208 | 24.96% | 0.66% |
| SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.30 M | $872,438 | -47.86% | 0.65% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 818,727 | $547,974 | 1.50% | 0.41% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 715,722 | $479,033 | 68.79% | 0.36% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 625,052 | $418,347 | 15.09% | 0.31% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 507,694 | $340,000 | 100.00% | 0.25% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 498,745 | $333,810 | 0.00% | 0.25% |
| MORGAN STANLEY | 11/14/2024 | 490,664 | $328,401 | 113.95% | 0.24% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 438,208 | $293,293 | 0.00% | 0.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 363,208 | $243,095 | 5.76% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 344,747 | $230,739 | -26.55% | 0.17% |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 11/13/2024 | 335,000 | $224,115 | 0.00% | 0.17% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 292,585 | $195,827 | 70.91% | 0.15% |
| DIAMETRIC CAPITAL, LP | 11/13/2024 | 288,552 | $193,127 | -35.68% | 0.14% |
| BARCLAYS PLC | 11/19/2024 | 277,682 | $185,000 | 195.97% | 0.14% |
| UBS GROUP AG | 11/14/2024 | 261,126 | $174,693 | 320.97% | 0.13% |
| AJOVISTA, LLC | 11/12/2024 | 257,644 | $172.44 M | 100.00% | 0.13% |
| JANE STREET GROUP, LLC | 11/15/2024 | 248,447 | $166,285 | 103.39% | 0.12% |
| RHUMBLINE ADVISERS | 11/12/2024 | 178,478 | $119,390 | -4.68% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 172,813 | $115,663 | 58.93% | 0.09% |
| XTX TOPCO LTD | 11/14/2024 | 157,642 | $105,510 | 41.71% | 0.08% |
| KNOTT DAVID M JR | 11/13/2024 | 154,071 | $103,000 | -14.87% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 136,800 | $91,656 | -14.34% | 0.07% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 125,504 | $84,000 | -23.59% | 0.06% |
| INVESCO LTD. | 11/12/2024 | 123,780 | $82,845 | 25.56% | 0.06% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 122,448 | $81,953 | -25.46% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 111,017 | $74,270 | 22.05% | 0.06% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 109,570 | $73,335 | 0.00% | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 105,083 | $70,332 | -35.68% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 92,266 | $61,754 | 45.41% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 89,850 | $60,137 | -0.61% | 0.04% |
| K2 PRINCIPAL FUND, L.P. | 11/15/2024 | 89,158 | $59,736 | -81.77% | 0.04% |
| AMUNDI | 11/13/2024 | 81,305 | $43,986 | 100.00% | 0.04% |
| CITADEL ADVISORS LLC | 11/14/2024 | 76,600 | $51,268 | 212.65% | 0.04% |
| JPMORGAN CHASE & CO | 12/26/2024 | 76,476 | $51,185 | 3.00% | 0.04% |
X4 Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 115 institutional investors and hedge funds held shares of X4 Pharmaceuticals, Inc.. The most heavily invested institutionals were:
LexAurum Advisors, LLC: 16,000
LAZARI CAPITAL MANAGEMENT, INC.: 10,000
Bain Capital Life Sciences Investors, LLC: 16.92 M
NEA Management Company, LLC: 14.99 M
BlackRock Funding, Inc. /DE: 11.21 M
VANGUARD GROUP INC: 8.44 M
50.08% of X4 Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 111.67 M shares in the last 24 months. This purchase volume represents approximately $53.60 M in transactions.